The GORE Septal Occluder, a cardiac implant made by W.L. Gore and Associates, has won the Best in Show Award at the 2013 Medical Design Excellence Awards (MDEA). The GORE Septal Occluder is ...

FLAGSTAFF, Ariz.--W. L. Gore & Associates today reported the first patient enrolled in the GORE® Septal Occluder Clinical Study evaluating the safety and efficacy of the new GORE Septal Occluder in ...

FLAGSTAFF, Ariz. Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc.

After a decade of clinical use* and more than 50,000 devices sold globally, the GORE® CARDIOFORM Septal Occluder continues a trusted legacy of safely advancing care. Now, after 10 years of clinical ...

GORE Septal Occluder. Manufactured and submitted by W. L. Gore & Associates Inc. (Flagstaff, AZ). The GORE Septal Occluder is a permanent implant delivered via a transcatheter approach. It is used to ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) announces positive results from its REDUCE Study assessing closure of patent foramen ovale (PFO) for the reduction of recurrent ...

- Published in the New England Journal of Medicine (NEJM), the REDUCE Study continues to show the largest reduction in recurrent ischemic stroke in all PFO shunt sizes over medical therapy alone. *, ¹ ...

September 12, 2006 ( updated December 4, 2006) — The US Food and Drug Administration (FDA) has approved an excimer laser system for primary laser-assisted in situ keratomileusis treatment to reduce or ...

FLAGSTAFF, Ariz. & MEXICO CITY--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced that Instituto Nacional De Cardiologia in Mexico City, Mexico, is the first hospital in the country to ...

FLAGSTAFF, Ariz., April 3, 2018 /PRNewswire/ -- Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W.

After a decade of clinical use* and more than 50,000 devices sold globally, the GORE CARDIOFORM Septal Occluder continues a trusted legacy of safely advancing care. FLAGSTAFF, Ariz., Jan. 20, 2022 ...